Cumberland Pharmaceuticals CPIX Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's deferred tax assets and other non-current assets?
- Cumberland Pharmaceuticals (CPIX) reported deferred tax assets and other non-current assets of $2.93M in Q1 2026.
- How has Cumberland Pharmaceuticals's deferred tax assets and other non-current assets changed year-over-year?
- Cumberland Pharmaceuticals's deferred tax assets and other non-current assets increased by 6.7% year-over-year, from $2.74M to $2.93M.
- What is the long-term trend for Cumberland Pharmaceuticals's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's deferred tax assets and other non-current assets has grown at a -1.7% compound annual growth rate (CAGR), from $3.23M to $2.97M.